GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lipum AB (OSTO:LIPUM) » Definitions » Dividends Received

Lipum AB (OSTO:LIPUM) Dividends Received


View and export this data going back to 2021. Start your Free Trial

What is Lipum AB Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.


Lipum AB (OSTO:LIPUM) Business Description

Traded in Other Exchanges
N/A
Address
Tvistevagen 48 C, Umea, SWE, 907 36
Lipum AB is a clinical-stage biopharmaceutical company specializing in the discovery and development of a novel treatment for chronic inflammatory diseases. The candidate SOL-116 is a humanized antibody designed to provide efficacious therapy by blocking a previously overlooked target molecule (BSSL) of the immune system. The development is supported by solid pre-clinical data for rheumatoid arthritis. Lipum also explores other inflammatory diseases with a high unmet medical need.